What question did this study set out to answer?

This study aims to evaluate the effectiveness and safety of deucravacitinib in treating moderate-to-severe plaque psoriasis in clinical practice.

April 28, 2026Clinical and Experimental Dermatology0 citations

View Full Paper

Deucravacitinib in Moderate-to-Severe Plaque Psoriasis: A Real-World Study of Effectiveness and Safety in Clinical Practice

ARAngelo Ruggiero RMR. Mozzillo MCMario Cordedda

Key Points

This study aims to evaluate the effectiveness and safety of deucravacitinib in treating moderate-to-severe plaque psoriasis in clinical practice.
Real-world study design assessing treatment outcomes.
Evaluation of effectiveness and safety profile in clinical settings.
Data collected from routine clinical practice.
Deucravacitinib demonstrated significant effectiveness in reducing psoriasis symptoms.
Sustained treatment effects were observed over the study period.
The safety profile was favorable, indicating it is a viable treatment option.

Abstract

In this real-world study, deucravacitinib showed significant and sustained effectiveness, together with a favorable safety profile, in patients with moderate-to-severe plaque psoriasis. These findings support its role as an effective oral targeted therapy in routine clinical practice.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Ruggiero et al. (Thu,) studied this question.

synapsesocial.com/papers/69f04e7d727298f751e72755 https://doi.org/https://doi.org/10.1093/ced/llag187

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper